{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"aggressive-nk-cell-leukemia","columns":[],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":[],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"not available","narrativeSourceChanges":[],"records":0,"sourceGroups":{}},"features":[],"ledeHtml":"A rare, highly aggressive, Epstein-Barr virus-associated leukemia, also known as aggressive NK-cell leukemia/lymphoma; it may represent the leukemic counterpart of nasal type extranodal NK/T-cell lymphomas. It affects primarily teenagers and young adults. It is characterized by the systemic proliferation of NK cells in the peripheral blood, bone marrow, liver, and spleen.","mondoId":"MONDO:0019470","node":{"canonicalSlug":"aggressive-nk-cell-leukemia","comparisons":[],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Aggressive NK-cell leukemia","originalSourceId":"ORPHA:86873","paragraphs":["A rare, highly aggressive, Epstein-Barr virus-associated leukemia, also known as aggressive NK-cell leukemia/lymphoma; it may represent the leukemic counterpart of nasal type extranodal NK/T-cell lymphomas. It affects primarily teenagers and young adults. It is characterized by the systemic proliferation of NK cells in the peripheral blood, bone marrow, liver, and spleen."],"rawAttribution":"MONDO:0019470","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:41:08Z","upstream":"MONDO:0019470","url":"https://rarediseases.info.nih.gov/diseases/10493"},"ownColumnKeys":[],"publication":"published","relationships":[{"kind":"parent","label":"mature T-cell and NK-cell non-Hodgkin lymphoma","mondoId":"MONDO:0000430","slug":"mature-t-cell-and-nk-cell-non-hodgkin-lymphoma"},{"kind":"parent","label":"chronic leukemia","mondoId":"MONDO:0001014","slug":null},{"kind":"parent","label":"T lymphoblastic leukemia/lymphoma","mondoId":"MONDO:0003537","slug":"t-lymphoblastic-leukemia-lymphoma"},{"kind":"parent","label":"T-cell acute lymphoblastic leukemia","mondoId":"MONDO:0004963","slug":"t-cell-acute-lymphoblastic-leukemia"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"published"},"records":[],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/10493\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0019470\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>MONDO:0019470</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A rare, highly aggressive, Epstein-Barr virus-associated leukemia, also known as aggressive NK-cell leukemia/lymphoma; it may represent the leukemic counterpart of nasal type extranodal NK/T-cell lymphomas. It affects primarily teenagers and young adults. It is characterized by the systemic proliferation of NK cells in the peripheral blood, bone marrow, liver, and spleen.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/10493\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"aggressive-nk-cell-leukemia","sourceDocuments":[{"name":"GARD: Aggressive NK-cell leukemia","reviewed":null,"source_release":"2026-10-25T03:41:08Z","url":"https://rarediseases.info.nih.gov/diseases/10493"},{"name":"MONDO: aggressive NK-cell leukemia","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0019470"}],"sourceNote":"","synonyms":["aggressive natural killer cell leukaemia","aggressive natural killer cell leukemia","aggressive NK cell leukaemia","aggressive NK cell leukemia","aggressive NK-cell leukaemia (morphologic abnormality)","aggressive NK-cell leukemia","aggressive NK-cell leukemia (morphologic abnormality)","aggressive NK-cell leukemia/lymphoma","aggressive NK-cell lymphoma","ANKCL","ANKL","leukaemia (disease) of natural killer cell","leukemia (disease) of natural killer cell","natural killer cell leukaemia (disease)","natural Killer cell leukemia","natural killer cell leukemia","natural killer cell leukemia (disease)","NK cell leukaemia","NK cell leukemia","NK-cell large granular lymphocyte leukaemia","NK-cell large granular lymphocyte leukemia","NK-cell leukaemia","NK-cell leukemia","NK-cell LGL leukaemia","NK-cell LGL leukemia"],"takeawayHtml":"","title":"aggressive NK-cell leukemia"},"schemaVersion":1}
